These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36810970)

  • 1. Expansion and commentary on a two generation approach to prenatal opioid exposure - a commentary on Conradt et al. (2023).
    Chaiyachati BH; Schiff D
    J Child Psychol Psychiatry; 2023 Apr; 64(4):579-582. PubMed ID: 36810970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Annual Research Review: Prenatal opioid exposure - a two-generation approach to conceptualizing neurodevelopmental outcomes.
    Conradt E; Camerota M; Maylott S; Lester BM
    J Child Psychol Psychiatry; 2023 Apr; 64(4):566-578. PubMed ID: 36751734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigating the associations between prenatal exposure to substances and intergenerational maltreatment and symptoms of psychopathology for adolescent girls from families with low income.
    Warmingham J; Petrenko C; Rockhold M; Alto M; Manly JT; Toth S
    Child Abuse Negl; 2024 Jan; 147():106594. PubMed ID: 38086214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatal Risk Factors and Perinatal and Postnatal Outcomes Associated With Maternal Opioid Exposure in an Urban, Low-Income, Multiethnic US Population.
    Azuine RE; Ji Y; Chang HY; Kim Y; Ji H; DiBari J; Hong X; Wang G; Singh GK; Pearson C; Zuckerman B; Surkan PJ; Wang X
    JAMA Netw Open; 2019 Jun; 2(6):e196405. PubMed ID: 31251378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal smoking and drinking during pregnancy and the risk for child and adolescent psychiatric disorders.
    Hill SY; Lowers L; Locke-Wellman J; Shen SA
    J Stud Alcohol; 2000 Sep; 61(5):661-8. PubMed ID: 11022804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between prenatal opioid exposure, neonatal opioid withdrawal syndrome, and neurodevelopmental and behavioral outcomes at 5-8 months of age.
    Bakhireva LN; Holbrook BD; Shrestha S; Leyva Y; Ashley M; Cano S; Lowe J; Stephen JM; Leeman L
    Early Hum Dev; 2019 Jan; 128():69-76. PubMed ID: 30554024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prenatal methadone exposure disrupts behavioral development and alters motor neuron intrinsic properties and local circuitry.
    Grecco GG; Mork BE; Huang JY; Metzger CE; Haggerty DL; Reeves KC; Gao Y; Hoffman H; Katner SN; Masters AR; Morris CW; Newell EA; Engleman EA; Baucum AJ; Kim J; Yamamoto BK; Allen MR; Wu YC; Lu HC; Sheets PL; Atwood BK
    Elife; 2021 Mar; 10():. PubMed ID: 33724184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive Outcomes of Young Children After Prenatal Exposure to Medications for Opioid Use Disorder: A Systematic Review and Meta-analysis.
    Nelson LF; Yocum VK; Patel KD; Qeadan F; Hsi A; Weitzen S
    JAMA Netw Open; 2020 Mar; 3(3):e201195. PubMed ID: 32186745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal Opioid Exposure and Neurodevelopmental Outcomes.
    Lee JJ; Saraiya N; Kuzniewicz MW
    J Neurosurg Anesthesiol; 2023 Jan; 35(1):142-146. PubMed ID: 36745179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Both parental psychopathology and prenatal maternal alcohol dependency can predict the behavioral phenotype in children.
    Staroselsky A; Fantus E; Sussman R; Sandor P; Koren G; Nulman I
    Paediatr Drugs; 2009; 11(1):22-5. PubMed ID: 19127947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What have birth cohort studies asked about genetic, pre- and perinatal exposures and child and adolescent onset mental health outcomes? A systematic review.
    Thompson L; Kemp J; Wilson P; Pritchett R; Minnis H; Toms-Whittle L; Puckering C; Law J; Gillberg C
    Eur Child Adolesc Psychiatry; 2010 Jan; 19(1):1-15. PubMed ID: 19636604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurodevelopmental Outcomes of Children Born to Opioid-Dependent Mothers: A Systematic Review and Meta-Analysis.
    Lee SJ; Bora S; Austin NC; Westerman A; Henderson JMT
    Acad Pediatr; 2020 Apr; 20(3):308-318. PubMed ID: 31734383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infant neurodevelopmental outcomes of prenatal opioid exposure and polysubstance use.
    Labella MH; Eiden RD; Tabachnick AR; Sellers T; Dozier M
    Neurotoxicol Teratol; 2021; 86():107000. PubMed ID: 34116198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testing the programming of temperament and psychopathology in two independent samples of children with prenatal substance exposure.
    Lin B; Ostlund BD; Conradt E; Lagasse LL; Lester BM
    Dev Psychopathol; 2018 Aug; 30(3):1023-1040. PubMed ID: 30068412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association Between Prenatal Opioid Exposure and Neurodevelopmental Outcomes in Early Childhood: A Retrospective Cohort Study.
    Wen X; Lawal OD; Belviso N; Matson KL; Wang S; Quilliam BJ; Meador KJ
    Drug Saf; 2021 Aug; 44(8):863-875. PubMed ID: 34100263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-occurrence of preconception maternal childhood adversity and opioid use during pregnancy: Implications for offspring brain development.
    Allen MC; Moog NK; Buss C; Yen E; Gustafsson HC; Sullivan EL; Graham AM
    Neurotoxicol Teratol; 2021; 88():107033. PubMed ID: 34601061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of Prenatal Exposure to Opioid Analgesics and Scholastic Skills in Children in Fifth Grade in Norway.
    Trønnes JN; Lupattelli A; Ystrom E; Nordeng H
    JAMA Netw Open; 2022 Jul; 5(7):e2222425. PubMed ID: 35852803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developmental Consequences of Prenatal Substance Use in Children and Adolescents.
    Guille C; Aujla R
    J Child Adolesc Psychopharmacol; 2019 Aug; 29(7):479-486. PubMed ID: 31038354
    [No Abstract]   [Full Text] [Related]  

  • 19. Physiological correlates of neurobehavioral disinhibition that relate to drug use and risky sexual behavior in adolescents with prenatal substance exposure.
    Conradt E; Lagasse LL; Shankaran S; Bada H; Bauer CR; Whitaker TM; Hammond JA; Lester BM
    Dev Neurosci; 2014; 36(3-4):306-15. PubMed ID: 25033835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prenatal opioid exposure - Increasing evidence of harm.
    Mactier H; Hamilton R
    Early Hum Dev; 2020 Nov; 150():105188. PubMed ID: 32958331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.